Basics Structure Therapeutics Inc. IPO Date: February 3, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.09B Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 3.22% Avg Daily Range (30 D): $0.43 | 2.06% Avg Daily Range (90 D): $0.63 | 2.97% Institutional Daily Volume Avg Daily Volume: .67M Avg Daily Volume (30 D): .72M Avg Daily Volume (90 D): .81M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 90 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 1,657 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $1.29M Avg Inst. Trade (90 D): $1.27M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.27M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $1.08M Avg Closing Volume: 36.63K     News Jun 20, 2025 @ 11:30 PM Structure Therapeutics Announces Two Late-Breaking... Source: N/A Apr 14, 2025 @ 3:12 PM Why Eli Lilly, Novo Nordisk, and Viking Therapeuti... Source: Rich Smith Jun 17, 2024 @ 1:53 PM Could Structure Therapeutics Become the Next Novo ... Source: newsfeedback@fool.com (Alex Carchidi) Jun 13, 2024 @ 6:30 AM Pfizer: Headwinds Dissipating, New Obesity Pipelin... Source: ONeil Trader Jun 11, 2024 @ 1:59 PM Structure Therapeutics (GPCR) Rallying on Obesity ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.87 $-.27 $-.22 Diluted EPS $-.87 $-.27 $-.22 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -143.32M $ -46.83M $ -36.48M Operating Income / Loss $ -182.52M $ -56.31M $ -47.06M Cost of Revenue $ $ $ Net Cash Flow $ 54.29M $ -17.39M $ -2.62M PE Ratio